<DOC>
	<DOC>NCT02415439</DOC>
	<brief_summary>The purpose of this study is to examine the safety, tolerability, and PK of various increasing single and multiple doses of VBP15 in healthy adult subjects.</brief_summary>
	<brief_title>A Phase 1 Single Ascending Dose and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of VBP15 in Healthy Adult Subjects</brief_title>
	<detailed_description />
	<criteria>For the Single Ascending Dose Study (SAD): Male subjects, ages 18 to 65 years, inclusive. For the Multiple Ascending Dose Study (MAD): Male subjects or female subjects of nonchildbearing potential ages 18 to 65, inclusive. For the MAD Study: Women of childbearing potential. Clinically significant abnormal laboratory parameters</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>adult</keyword>
	<keyword>volunteers</keyword>
</DOC>